Advice
following an abbreviated submission
ethinylestradiol 30/40 plus levonorgestrel 50/75/125 microgram (TriRegol®): is accepted for use within NHS Scotland.
Indication under review: oral contraception.
For patients in whom phasic ethinylestradiol and levonorgestrel is an appropriate contraceptive, TriRegol® provides an alternative to the existing preparation at lower cost.
Download detailed advice69KB (PDF)
Medicine details
- Medicine name:
- ethinylestradiol and levonorgestrel (TriRegol)
- SMC ID:
- 645/10
- Indication:
- Oral contraceptive
- Pharmaceutical company
- Consilient Health Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 11 October 2010